Print This Page | Back to Web Page

Press Releases

Showing 1-35 of 281

First 1 2 3 4 5 6 7 8 9 Next Last

2012
May
May 16	Abbott Launches PediaSure SideKicks^® Clear for Picky Eaters
May 15	Abbott's XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy
May 7	Abbott Reaches Settlement Agreement on Depakote
May 4	Abbott Recognizes Winners of Supplier Excellence Award
May 3	Abbott Announces Collaboration with Syngene to Open First Nutrition R&D Center in India
May 3	Abbott to Acquire Action Pharma's Investigational Compound, AP214, in Phase 2b Development for Prevention of Acute Kidney Injury
May 2	Abbott to Present at Deutsche Bank 37th Annual Health Care Conference

April
April 25	New Products from Abbott’s EAS® Sports Nutrition Brand Help Athletes Improve Post-Workout Recovery and Meet Fitness Goals
April 23	Abbott and St. Jude Medical Broaden Alliance for Cardiovascular Products in the United States
April 20	Abbott Receives U.S. FDA Clearance to Use iFS Advanced Femtosecond Laser Technology for Arcuate Incisions in Cataract Surgery
April 19	Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the Treatment of Hepatitis C
April 19	Abbott Presents Positive Results from Phase 2 "Pilot" Study of an Interferon-Free Combination Regimen for the Treatment of Hepatitis C
April 18	Abbott Reports Double-Digit Ongoing Earnings-Per-Share Growth in First Quarter; Raises Full-Year 2012 Outlook
April 17	Abbott Licenses Biomarkers for Use in Differentiating Aggressive from Nonaggressive Prostate Cancer
April 17	Abbott’s Investigational Treatment for Advanced Parkinson’s Disease Demonstrates Positive Results in Phase 3 Clinical Trial
April 11	Abbott's HUMIRA® (adalimumab) Approved in Europe for Treatment of Ulcerative Colitis (UC)
April 9	Abbott Receives Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent in Japan
April 4	Abbott to Present Positive Phase 2 Results from Multiple Interferon-Free Studies of Combination Regimens for the Treatment of Hepatitis C

March
March 30	Abbott's PLEX-ID Molecular System and Tests for Broad Microbial Identification Obtain CE Marking
March 28	Abbott Hosts Conference Call for First-Quarter Earnings
March 21	Abbott Selects AbbVie as New Name for Future Research-Based Pharmaceutical Company
March 20	Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012
March 15	Abbott Announces Patient Enrollment in Two Phase 3 Studies of HUMIRA^®(adalimumab) for Moderate to Severe Hidradenitis Suppurativa - (U.S.)
March 15	Abbott Announces Patient Enrollment in Two Phase 3 Studies of HUMIRA^® (adalimumab) for Moderate to Severe Hidradenitis Suppurativa - (Europe)
March 12	New Publication Presents Comparative Efficacy Data for Abbott's Zemplar^®(paricalcitol) in Treating Secondary Hyperparathyroidism in Hemodialysis Patients
March 8	Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System Receives FDA Clearance
March 7	Abbott to Present at Barclays Capital 2012 Global Healthcare Conference
March 7	Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease
March 6	Abbott and Merck Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy
March 5	Abbott to Collaborate on Rapid Molecular Test to Identify Serious Infections in Bones and Joint
March 2	Abbott's STARLIMS Business Acquires Distribution Partners to Build International Presence
March 1	Abbott to Build Nutrition Manufacturing Facility in Ohio

February
February 29	Abbott and Galapagos Announce Global Collaboration for Novel Oral Therapy, GLPG0634, in Phase II to Treat Autoimmune Diseases
February 23	Abbott to Present at Cowen and Company 32nd Annual Health Care Conference
February 23	Abbott Collaborates with Leading U.S. Forensics Center on Human Identification Testing

First 1 2 3 4 5 6 7 8 9 Next Last

Narrow by Year

Narrow to Show

Home | Site Map | Contact Us | Privacy Policy | Terms of Use

Copyright © 2006, 2012 Abbott Laboratories. Abbott Park, Illinois, U.S.A.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company.